Clinical Trial Update: A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen [Phase 3]

View source ↗

Summary

A Phase IIIb study comparing two boosted protease inhibitor-based HAART regimens in HIV-infected patients experiencing their first virologic failure while recei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Boosted protease inhibitor-based HAART regimen A
• Boosted protease inhibitor-based HAART regimen B

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 3 | Status: COMPLETED